Presentations we supply
- Injection 20 mg
- Injection 40 mg
- Injection 60 mg
Tell us whether you need the originator brand or a generic, the strength, pack and quantity, and the destination country.
Send Enquiry for EnoxaparinReference information
Summarised from the product information for Inhixa (a biosimilar medicine authorised in the EU). Always follow the product information approved in your own country.
- Active substance
- Enoxaparin
- Pharmacotherapeutic group
- Antithrombotic agents, heparin group (ATC code B01AB05)
- Authorised uses
- Prevention of venous thromboembolism in surgical patients and in acutely ill medical patients with reduced mobility
- Treatment of deep vein thrombosis and pulmonary embolism
- Extended treatment of deep vein thrombosis and pulmonary embolism in patients with active cancer
- Prevention of clotting in the extracorporeal circuit during haemodialysis
- Acute coronary syndrome
- Storage (unopened)
- Store below 25 °C. Do not freeze.
Supply from Bio Bridge Pharma
- The registration route and import licence are confirmed for your destination before we make an offer.
- Documents agreed before you order, such as the batch certificate of analysis and a CoPP where your regulator needs one.
- Named patient supply where the destination country's rules allow it.
Sources
- Product information for Inhixa: www.ema.europa.eu